Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Nintedanib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nintedanib 100mg capsules
0801050BTAAAAAA
|
Nintedanib | Nintedanib | Malignant Disease and Immunosuppression | 3 |
|
Ofev 150mg capsules
0801050BTBCABAB
|
Ofev | Nintedanib | Malignant Disease and Immunosuppression | 1 |
|
Nintedanib 150mg capsules
0801050BTAAABAB
|
Nintedanib | Nintedanib | Malignant Disease and Immunosuppression | No data available |
|
Ofev 100mg capsules
0801050BTBCAAAA
|
Ofev | Nintedanib | Malignant Disease and Immunosuppression | No data available |
|
Vargatef 100mg capsules
0801050BTBBAAAA
|
Vargatef | Nintedanib | Malignant Disease and Immunosuppression | No data available |
|
Vargatef 150mg capsules
0801050BTBBABAB
|
Vargatef | Nintedanib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.